# Study to Assess the Safety, Tolerability, Pharmacokinetics (PK) and Preliminary Efficacy of AZD2014

> **NCT01026402** · PHASE1 · COMPLETED · sponsor: **AstraZeneca** · enrollment: 172 (actual)

## Conditions studied

- Advanced Solid Malignancies

## Interventions

- **DRUG:** AZD2014

## Key facts

- **NCT ID:** NCT01026402
- **Lead sponsor:** AstraZeneca
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-12
- **Primary completion:** 2014-08
- **Final completion:** 2014-08
- **Target enrollment:** 172 (ACTUAL)
- **Last updated:** 2016-02-11


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01026402

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01026402, "Study to Assess the Safety, Tolerability, Pharmacokinetics (PK) and Preliminary Efficacy of AZD2014". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT01026402. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*